Sector Gamma As Agios Pharmaceuticals, Inc. Transaction History
Sector Gamma As
- $309 Million
- Q3 2024
A detailed history of Sector Gamma As transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Sector Gamma As holds 67,908 shares of AGIO stock, worth $2.24 Million. This represents 0.98% of its overall portfolio holdings.
Number of Shares
67,908
Previous 121,844
44.27%
Holding current value
$2.24 Million
Previous $5.25 Million
42.57%
% of portfolio
0.98%
Previous 2.05%
Shares
9 transactions
Others Institutions Holding AGIO
# of Institutions
232Shares Held
58.1MCall Options Held
403KPut Options Held
469K-
Farallon Capital Management LLC San Francisco, CA5.66MShares$187 Million1.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.55MShares$183 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$160 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.74MShares$123 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$93.6 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.81B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...